---

Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate BioPharma

Recently, Gill has been involved in launching BioCelerate, a new subsidiary of TransCelerate, and its first initiative, Toxicology Data Sharing. “TransCelerate delivered some significant solutions that are positively impacting clinical development, including the Shared Investigator Platform and the Investigator Registry that work together to streamline investigative site communication, information sharing and monitoring tasks,” says Dalvir.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016